Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Johnson; Dale E.
Address:
Emeryville, CA
No. of patents:
6
Patents:












Patent Number Title Of Patent Date Issued
8017116 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis September 13, 2011
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7897148 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis March 1, 2011
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7879987 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis February 1, 2011
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7776585 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis August 17, 2010
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7285268 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis October 23, 2007
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of
7276589 Chimeric and humanized antibodies to .alpha.5.beta.1 integrin that modulate angiogenesis October 2, 2007
The present invention provides chimeric and humanized antibodies that specifically recognize .alpha.5.beta.1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of










 
 
  Recently Added Patents
Device and method for unified codes
(4933
Lamp body with integrally molded heat sink
Electrophoresis display having touch screen and method for driving the touch screen
Systems and methods for simultaneously configuring multiple independent backups
Medical injector
Gaze tracking password input method and device utilizing the same
  Randomly Featured Patents
Manufacture of precipitated calcium carbonate of improved color and stable crystalline form
Pre-molded header with universal tip-to-tip feedthru adaptor
Method for full-bandwidth source deghosting of marine seismic streamer data
Outdoors survival kit
Method of manufacturing a semiconductor package
Hot-rolled steel bar or wire rod
Electrical cable
Bumper of motor vehicle
Air balance hoist with load position indicator
Methods of forming a metal layer using transition metal precursors